Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 14 of 100 as at 1 Aug 2026 — in the weakest quartile.
Consensus tells you what everyone already believes. The model scores Canton Strategic Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (71): Smaller than most of the companies we track.
Value (9): The shares cost a lot relative to the profits and assets behind them.
The rank is the raw material. Whether the rules would actually own Canton Strategic Holdings, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on CNTN, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 84% of US stocks
Cheaper than 88% of US stocks
Cheaper than 73% of US stocks
Higher than 35% of US stocks
Higher than 30% of US stocks
Higher than 25% of US stocks
Higher than 25% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CNTN appears on the weeks it earns a place.
Canton Strategic Holdings, Inc. announced that Sean Galvin, Pamela L. Carter, and Rishi Nangalia were elected as directors to its Board of Directors, effective July 13, 2026, following the Company's Annual Shareholder Meeting.
Why it matters — A CNTN watcher would care because the appointments are described as strengthening governance as the Company advances its Canton Network strategy.
As at 1 Aug 2026, Canton Strategic Holdings, Inc. ranks 14 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (71 of 100).
No analyst covering Canton Strategic Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CNTN are extrapolating price history, which says nothing about the business.
Canton Strategic Holdings, Inc. is a publicly traded company focused on leveraging Canton Coin to support the Canton Network, the first privacy-enabled public blockchain processing $9 trillion in monthly transaction volume.
The most recent item we track (PRNewsWire, 28 July 2026): "Three New Directors Elected to the Board of Canton Strategic Holdings, Inc.". Canton Strategic Holdings, Inc. announced that Sean Galvin, Pamela L. Carter, and Rishi Nangalia were elected as directors to its Board of Directors, effective July 13, 2026, following the Company's Annual Shareholder Meeting.
Canton Strategic Holdings, Inc. is a publicly traded company focused on leveraging Canton Coin to support the Canton Network, the first privacy-enabled public blockchain processing $9 trillion in monthly transaction volume. Formerly Tharimmune, Inc., it rebranded effective February 18, 2026, aligning with its digital asset treasury strategy initiated through a $545 million private placement in November 2025. The company drives value via Canton Coin acquisition, operation of a Super Validator on the network, and investments in applications that promote institutional utility and adoption across capital markets. It remains the first and only publicly traded entity backed by the Canton Foundation, featuring institutional expertise on its board, including former CFTC Commissioner Jill Sommers. Additionally, Canton Strategic Holdings maintains clinical-stage biotech research and development in inflammation and immunology. Key milestones include a $55 million registered offering for expansion and quarterly ecosystem reporting commitments. Positioned at the forefront of digitizing traditional financial markets, it facilitates onchain innovations like tokenized U.S. Treasury securities and enterprise payroll solutions.
CEO Mr. Mark Wendland · 12 employees · United States · https://www.cantonstrategic.com